Angle Share Discussion Threads

[fhmktg] 19/11/2024 08:49

Tough comments PWhite
All will be revealed in the next couple of months.

[pwhite73] 19/11/2024 08:45

I note AGL has lost its recent gains again. The trade patterns point to the fact they are forward selling the next placing. I am not convinced of any big pharma interest in their product or that the directors are even interested in a takeover. Far more lucrative to rinse retail shareholders year after year.

[pwhite73] 19/11/2024 08:43

I've reported m-night10 for spamming. If you have to spam on 100 threads to promote a stock that's because it utterly worthless. If POLX is a takeover target than why does he have to spam.

[bagpuss67] 19/11/2024 07:58

Another for the filter list.

[mesquida] 19/11/2024 07:52

m_night10 now beginning to irritate me !

[m_night10] 19/11/2024 07:34

#POLX next less than half the mcap of #AGL but a stronger cash position and higher revenues and growth.

POLX Polarean Imaging 1.6p I fancy to fill the gap to 3.2p and head to 10p+. Mcap is peanuts and cash position is much longer to Q2 2026 and revenue are higher and growing even more quickly than this.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil in 2025 Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations.

Putting this UK recovery play potential on radars as used to trade at 100p and has made significant commercial progress since FDA approval.

Massive takeover target and will be sold for 20p+ share price.

1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M.

APPROX 13P SHARE PRICE EQUIVALENT FOR POLX


2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M

APPROX 48P SHARE PRICE EQUIVALENT FOR POLX


3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million.

APPROX 22P SHARE PRICE EQUIVALENT FOR POLX

4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout

POLX easy buyout target more massive premiums as per the above imv. DYOR, not advice.

[muffster] 18/11/2024 19:59

Surprised that Bone idle has popped up to say how much he/she/they hate this share.

[kryptonsnake] 18/11/2024 19:12

Says the guy who posted just to tell us he won't be investing

Stick with your helium exploration company and enjoy missing out on some real gains



sent from my iPhone

[divmad] 18/11/2024 16:43

What a thoroughly inane post.

[kryptonsnake] 18/11/2024 16:10

Another 9% up today and still 20% below placing price

This has got a long way to go

Expect more idiots showing up as the price continues to increase because they are too scared to buy in now

Enjoy staying poor



sent from my iPhone

[muffster] 18/11/2024 14:50

Stay worried then. Laters

[seball] 18/11/2024 14:22

End of April we were told 6 Month development phase. Expecting an update imminently . This could rerate the share price. BUY

"Under the agreement, ANGLE will develop a novel methodology for CTC micronuclei detection based on its existing pKAP1 CTC-based DDR assay, which measures expression of a key protein in the DNA damage response. Assay development will take place in ANGLE's laboratories in Guildford, UK, and follows the Company's development and launch of two highly sensitive and specific DDR assays in 2023. The 6-month development phase is worth an initial £150,000 to ANGLE."

[boris cobaka] 18/11/2024 14:09

hxxps://www.marketscreener.com/quote/stock/ANGLE-PLC-4004594/news/ANGLE-PLC-RESULTS-FROM-WORK-TO-DEVELOP-A-PARSORTIX-BASED-Her2-assay-KIT-SHOWCASED-AT-INTERNATIONAL-48394835/


interesting...... 8)

[fhmktg] 18/11/2024 13:43

Game over even?

[robizm] 18/11/2024 13:35

What worries me is no follow on contract and technically then company is running on fumes

[m_night10] 18/11/2024 13:19

#POLX next less than half the mcap of #AGL but a stronger cash position and higher revenues and growth.

POLX Polarean Imaging 1.6p I fancy to fill the gap to 3.2p and head to 10p+. Mcap is peanuts and cash position is much longer to Q2 2026 and revenue are higher and growing even more quickly than this.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil in 2025 Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations.

Putting this UK recovery play potential on radars as used to trade at 100p and has made significant commercial progress since FDA approval.

Massive takeover target and will be sold for 20p+ share price.

1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M.

APPROX 13P SHARE PRICE EQUIVALENT FOR POLX


2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M

APPROX 48P SHARE PRICE EQUIVALENT FOR POLX


3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million.

APPROX 22P SHARE PRICE EQUIVALENT FOR POLX

4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout

POLX easy buyout target more massive premiums as per the above imv. DYOR, not advice.

[fhmktg] 18/11/2024 12:50

Getting a follow up contract for phase II/III from the current contract would be a useful move.
Getting a separate contract,specifically for utility with an existing marketed product would be a game changer.

[robizm] 18/11/2024 12:40

That does not make sense as they could have bought the company before the contracts and even been a big investor at the last placement as they would have front row seats as to how well the product is working for them.

[muffster] 18/11/2024 12:16

And the rest. We have a 70p brokers note out and I'm expecting buy out by AZ

[atmysignal] 18/11/2024 10:11

AstraZeneca rns due30p